Description
PRINCIPIO ACTIVO: DAPAGLIFLOZINA
LIXISENATIDA
80 MG VITAMINA E 18
HEMLIBRA® 150 mg/mL es un medicamento anticuerpo monoclonal cuyo principio activo es Emicizumab
JGA DL 3ML 23X25 C5 DOMPERIDONA PRINCIPIO ACTIVO: DAPAGLIFLOZINADOSIS: 23X25 MM PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
